280
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES and LETTERS Infectious Disease

Prevalence of Pneumococcal Bacteremia in Children with Sickle Cell Disease

, , &
Pages 432-436 | Received 12 Mar 2013, Accepted 12 Mar 2013, Published online: 09 Apr 2013

REFERENCES

  • Cober MP, Phelps SJ. Penicillin prophylaxis in children with SCD. J Pediatr Pharmacol Ther. 2010;15:152–159.
  • Gaston MH, Verter JI, Woods G, Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593–1599.
  • Powars DR. Natural history of SCD—the first ten years. Semin Hematol. 1975;12:267–285.
  • Hord J, Byrd R, Stowe L, Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with SCD. J Pediatr Hematol Oncol. 2002;24:470–472.
  • Ammann AJ, Addiego J, Wara DW, Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med. 1977;297:897–900.
  • Weintrub PS, Schiffman G, Addiego JE, Jr., Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J Pediatr. 1984;105:261–263.
  • Darkes MJ, Plosker GL. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr Drugs. 2002;4:609–630.
  • Narang S, Fernandez ID, Chin N, Bacteremia in children with sickle hemoglobinopathies. J Pediatr Hematol Oncol. 2012;34:13–16.
  • Rogovik AL, Friedman JN, Persaud J, Goldman RD. Bacterial blood cultures in children with SCD. Am J Emerg Med. 2010;28:511–514.
  • Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric SCD-related mortality in the United States, 1983–2002. J Pediatr. 2009;154:541–545.
  • Ellison AM, Ota KV, McGowan KL, Smith-Whitley K. Pneumococcal bacteremia in a vaccinated pediatric SCD population. Pediatr Infect Dis J. 2012;31:534–536.
  • Adamkiewicz TV, Silk BJ, Howgate J, Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with SCD in the first decade of life. Pediatrics. 2008;121:562–569.
  • Halasa NB, Shankar SM, Talbot TR, Incidence of invasive pneumococcal disease among individuals with SCD before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44:1428–1433.
  • McCavit TL, Quinn CT, Techasaensiri C, Rogers ZR. Increase in invasive Streptococcus pneumoniae infections in children with SCD since pneumococcal conjugate vaccine licensure. J Pediatr. 2011;158:505–507.
  • Sucher AJ, Chahine EB, Nelson M, Sucher BJ. Prevnar 13, the new 13-valent pneumococcal conjugate vaccine. Ann Pharmacother. 2011;45:1516–1524.
  • West DC, Andrada E, Azari R, Predictors of bacteremia in febrile children with SCD. J Pediatr Hematol Oncol. 2002;24:279–283.
  • Alpern ER, Alessandrini EA, Bell LM, Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505–511.
  • Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in SCD: time to positivity and clinical outcome. J Pediatr Hematol Oncol. 2003;25:390–395.
  • Williams LL, Wilimas JA, Harris SC, Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with SCD. J Pediatr Hematol Oncol. 1996;18:257–261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.